Psyence Biomedical Ltd. (PBMWW) stock
PBMWWNasdaqPharmaceutical PreparationsFiscal year ends March 31Also trades as PBM
$0.01−0.00 (-2.50%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Psyence Biomedical cash
Cash and short-term investments held at the end of each period.
Psyence Biomedical's cash was $7.44M at Mar 31, 2026. For fiscal 2026 it was $7.44M, up 21.3% from the year before. The highest annual figure on record is $7.44M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $7.44M | +21.3% |
| FY2025 | Mar 31, 2025 | $6.14M | +736.8% |
| FY2024 | Mar 31, 2024 | $733.19K | -45.0% |
| FY2023 | Mar 31, 2023 | $1.33M | -23.9% |
| FY2022 | Mar 31, 2022 | $1.75M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Mar 31, 2026 | $7.44M | +915.4% |
| Q2 FY2026 | Sep 30, 2025 | $7.15M | +875.2% |
| Q4 FY2025 | Mar 31, 2025 | $6.14M | +913.3% |
| Q2 FY2025 | Sep 30, 2024 | $1.93M | +44.8% |
| Q1 FY2025 | Jun 30, 2024 | $733.19K | -58.2% |
| Q4 FY2024 | Mar 31, 2024 | $733.19K | – |
| Q2 FY2024 | Sep 30, 2023 | $605.48K | – |
| Q4 FY2023 | Mar 31, 2023 | $1.33M | – |
| Q4 FY2022 | Mar 31, 2022 | $1.75M | – |